Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
YYuki Gosei Kogyo Co.,Ltd. logo
4531TSE Standard

Yuki Gosei Kogyo Co.,Ltd.

有機合成薬品工業 Yahoo Finance

Recent & upcoming events

Jul 31
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 23
Shareholder meeting 21:30
Shareholders' meeting
Venue: アルカディア市ヶ谷（私学会館）6階「霧島」の間 東京都千代田区九段北四丁目2番25号 Details
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 16
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 1
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 19
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Jun 4
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥15.45B YoY +2.1%
Operating income ¥383M margin 2.5%
Net income ¥313M YoY -65.1%
EPS —
P/E —
ROE —

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥16.00B +3.6%
Operating income ¥550M +43.6%
Net income ¥600M +91.7%
EPS ¥28 —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q2
Revenue ¥3.83B¥2.94B¥2.86B¥3.13B¥4.01B—
Operating income ¥351M¥309M¥-69M¥249M¥639M—
Net income ¥278M¥232M¥-62M¥186M¥420M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 39.1%未開示 60.9%202120222023202420252026
事業法人国内機関未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

ニプロ株式会社 15.3%ニプロ株式会社長瀬産業株式会社 5.1%長瀬産業株式会社保土谷化学工業株式会社 5.1%保土谷化学工業株式会社大鵬薬品工業株式会社 3.1%大鵬薬品工業株式会社住友商事ケミカル株式会社 2.5%住友商事ケミカル株式会社ゼリア新薬工業株式会社 2.2%ゼリア新薬工業株式会社あすか製薬株式会社 1.7%あすか製薬株式会社サンヨーファイン株式会社 1.4%サンヨーファイン株式会社喜美運送株式会社 1.4%喜美運送株式会社株式会社山口薬品商会 1.4%株式会社山口薬品商会202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
ニプロ株式会社 3,296,000 15.3% Yuho (EDINET)
長瀬産業株式会社 1,098,000 5.1% Yuho (EDINET)
保土谷化学工業株式会社 1,098,000 5.1% Yuho (EDINET)
大鵬薬品工業株式会社 671,000 3.1% Yuho (EDINET)
住友商事ケミカル株式会社 535,000 2.5% Yuho (EDINET)
ゼリア新薬工業株式会社 483,000 2.2% Yuho (EDINET)
あすか製薬株式会社 366,000 1.7% Yuho (EDINET)
サンヨーファイン株式会社 306,000 1.4% Yuho (EDINET)
喜美運送株式会社 304,000 1.4% Yuho (EDINET)
株式会社山口薬品商会 303,000 1.4% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

4/9 4 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 1.2%
— Positive operating cash flow No data
✗ ROA improved YoY 3.3% → 1.2%
— Operating CF exceeds net income (accrual quality) No data
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 48.8% → 52.4%
— Current ratio improved No data
✓ No dilution (shares outstanding did not increase) 21,974,000 → 21,974,000
— Gross margin improved No data
✓ Asset turnover improved 0.56× → 0.60×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio —
Current ratio —
Years of positive operating CF —
Payout ratio 69%
Latest fiscal year result Profit (net income ¥313M)

Performance history

Last 10 years
0億円39億円77億円116億円154億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 104101103107111124128129151154
Operating income 4.552.050.493.122.184.138.9711.312.23.83
Ordinary income 4.122.260.234.011.763.976.6011.311.43.03
Net income 3.551.251.04-0.422.882.485.567.768.963.13
Total assets 195215216202210212221244269257
Equity 109111109105109110115124131135

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ————¥13¥11¥26¥36¥41—
ROE ——————————
Operating CF ——————————
Investing CF ——————————
Financing CF ——————————
FCF ——————————

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data